<img src="https://dominatethemarkets.com/wp-content/uploads/2023/05/dominate_the_markets.png" class="logo-image" alt="Dominate The Markets" data-at2x="https://dominatethemarkets.com/wp-content/uploads/2023/05/dominate_the_markets.png" />

<img width="740" height="357" src="https://dominatethemarkets.com/wp-content/uploads/2023/03/img-onso-system-user-7DmLXk-740x357.jpeg" class="attachment-motive-alt-slider size-motive-alt-slider wp-post-image" alt="" decoding="async" title="Biotech stock Pacific Biosciences could return 50% in 12 months: TD Cowen" srcset="https://dominatethemarkets.com/wp-content/uploads/2023/03/img-onso-system-user-7DmLXk-740x357.jpeg 740w, https://dominatethemarkets.com/wp-content/uploads/2023/03/img-onso-system-user-7DmLXk-352x169.jpeg 352w" sizes="(max-width: 740px) 100vw, 740px" />

Biotech stock Pacific Biosciences could return 50% in 12 months: TD Cowen

0

By on March 31, 2023 Stock Top News

[#item_full_content]

<img alt='' src='https://secure.gravatar.com/avatar/?s=78&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/?s=156&d=mm&r=g 2x' class='avatar avatar-78 photo avatar-default' height='78' width='78' decoding='async'/>

Previous ArticleCore PCE rose again in February: time to sell semiconductor stocks?

Next Article Nikola shares down 15% on secondary stock offering: buy the dip?